FogPharma today announced the appointment of Tony Gibney as Chief Financial Officer and Chief Business Officer. Mr. Gibney brings over 25 years of life science investment banking experience dedicated to advising biotech companies in the U.S. and Europe on substantial corporate M&A, partnering transactions, as well as executing financing transactions. Following his career in investment banking, Mr. Gibney transitioned to the biotech industry to burnish his corporate strategy and business development skills and gain operational expertise, and to become directly involved in advancing compounds to treat diseases of high unmet need.

https://www.prnewswire.com/news-releases/fogpharma-appoints-tony-gibney-as-chief-financial-officer-and-chief-business-officer-301054715.html?tc=eml_cleartime